2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
- PMID: 20570146
- DOI: 10.1016/j.bmcl.2010.05.008
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
Abstract
Recently a class of compounds known as triple reuptake inhibitors has emerged as a new strategy for the treatment of depression. These compounds work by simultaneously inhibiting the synaptic reuptake of serotonin, norepinephrine and dopamine. In this Letter we describe the optimization of a novel series of 2-substituted N-aryl piperazine based triple reuptake inhibitors.
2010 Elsevier Ltd. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Medical
